Vista previa | Fecha de publicación | Título | Autor(es) | Acceso |
![Circulating miRNA-21 is an innovative biomarker for cardiovascular events in erectile dysfunction patients.pdf.jpg](/retrieve/39ae97c2-f354-4c4d-9ff6-5f81d21a0ee1/Circulating%20miRNA-21%20is%20an%20innovative%20biomarker%20for%20cardiovascular%20events%20in%20erectile%20dysfunction%20patients.pdf.jpg) | 21-mar-2024 | Circulating miRNA-21 is an innovative biomarker for cardiovascular events in erectile dysfunction patients | Agulló, Laura; Segura, Ana; Ortuño-Miquel, Samanta; Brinca, Ana Teresa; Micol-Ponce, Rosa; Arrarte, Vicente; Ponce, María Rosa; Miró-Martínez, Pau; Zandonai, Thomas; Peiró, Ana | ![](/image/openAccess.png) |
![Clinical prediction of opioid use disorder in chronic pain patients. A cohort-retrospective study with a pharmacogenetic approach.pdf.jpg](/retrieve/a558ddfe-37b5-4dd4-8872-0167dd3ecf23/Clinical%20prediction%20of%20opioid%20use%20disorder%20in%20chronic%20pain%20patients.%20A%20cohort-retrospective%20study%20with%20a%20pharmacogenetic%20approach.pdf.jpg) | 12-abr-2024 | Clinical prediction of opioid use disorder in chronic pain patients: a cohort-retrospective study with a pharmacogenetic approach | Escorial, Mónica; Muriel, Javier; Agulló, Laura; Zandonai, Thomas; Margarit, César; Morales, Domingo; Peiró, Ana | ![](/image/openAccess.png) |
![TESIS Agulló Antón_Laura.pdf.jpg](/retrieve/07ccf859-723a-4933-b588-0c3bdfc052a6/TESIS%20Agull%c3%b3%20Ant%c3%b3n_Laura.pdf.jpg) | 12-sep-2023 | Impacto del sexo y el género en la respuesta analgésica al tratamiento del dolor crónico modulada por factores farmacogenéticos y epigenéticos | Agulló, Laura | ![](/image/openAccess.png) |
![239 GÓMEZ GIL,ALBA-Memoria TFM.pdf.jpg](/retrieve/61f584c2-33bd-430c-a7cb-ff3a5405e647/239%20G%c3%93MEZ%20GIL%2cALBA-Memoria%20TFM.pdf.jpg) | 22-jun-2022 | Influencia de la farmacogenética en el tratamiento del dolor crónico no oncológico con opiodes: análisis descriptivo e importancia del sexo | Gómez Gil, Alba | ![](/image/openAccess.png) |
![Pharmacogenetic Guided Opioid Therapy Improves Chronic.pdf.jpg](/retrieve/1772878b-270e-4cd7-bc03-a7cb5fee6471/Pharmacogenetic%20Guided%20Opioid%20Therapy%20Improves%20Chronic.pdf.jpg) | 2023 | Pharmacogenetic Guided Opioid Therapy Improves Chronic Pain Outcomes and Comorbid Mental Health: A Randomized, Double-Blind, Controlled Study | Agulló, Laura; Aguado, Isidro; Muriel, Javier; Margarit, César; Gómez, Alba; Escorial, Mónica; Sánchez, Astrid; Fernández, Alicia; Peiró, Ana | ![](/image/openAccess.png) |
![Sex Differences in Opioid Response Linked to OPRM1 and COMT genes DNA Methylation-Genotypes Changes in Patients with Chronic Pain.pdf.jpg](/retrieve/ea9a64a5-72c7-4efd-b163-0458923f5c5e/Sex%20Differences%20in%20Opioid%20Response%20Linked%20to%20OPRM1%20and%20COMT%20genes%20DNA%20Methylation-Genotypes%20Changes%20in%20Patients%20with%20Chronic%20Pain.pdf.jpg) | 13-may-2023 | Sex Differences in Opioid Response Linked to OPRM1 and COMT genes DNA Methylation/Genotypes Changes in Patients with Chronic Pain | Agulló, Laura; Muriel, Javier; Margarit, César; Escorial, Mónica; Garcia, Diana; Herrero, María José; Hervás, David; Sandoval, Juan; Peiró, Ana | ![](/image/openAccess.png) |
![Sex Differences in Oxycodone Naloxone vs. Tapentadol in Chronic Non-Cancer Pain. An Observational Real-World Study.pdf.jpg](/retrieve/a32f4d7a-81ff-4222-8a14-e364812dcd50/Sex%20Differences%20in%20Oxycodone%20Naloxone%20vs.%20Tapentadol%20in%20Chronic%20Non-Cancer%20Pain.%20An%20Observational%20Real-World%20Study.pdf.jpg) | 2-oct-2022 | Sex Differences in Oxycodone/Naloxone vs. Tapentadol in Chronic Non-Cancer Pain: An Observational Real-World Study | Barrachina, Jordi; Margarit, Cesar; Muriel, Javier; López Gil, Vicente; López Gil, Santiago; Ballester, Purificación; Mira-Lorente, Laura; Agulló, Laura; Peiró, Ana | ![](/image/openAccess.png) |